What the label lists and what reports show
Oxidronate side effects
Oxidronate's FDA label lists its adverse reactions in its own words. FAERS holds 135 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is nausea (16 reports).
- No generic listed
Check it at the source: the oxidronate FDA label on DailyMed (effective December 5, 2025); the FDA FAERS public dashboard.
What does the label list?
From the label: adverse reactionsThe following adverse reactions associated with the use of Technescan HDP have been reported: hypersensitivity reactions, including life-threatening reactions, as well as nausea, vomiting, and injection site reactions.
Source: FDA drug label, Curium US LLC, effective December 5, 2025 (SPL set 6fc2e41e-a1bf-4e0f-924a-88be0372d4af), via openFDA; the full label on DailyMed
What do FAERS reports show?
135 reports list oxidronate among the medicines taken, each a report of something that happened, not proof the medicine caused it; 3 are coded as a death and 18 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 24 reactions below, 2 are named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.
The 25 most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms
What next?
- Oxidronate: the full record
- label, generics, price, shortages, recalls
- Report a side effect to the FDA
- MedWatch
- Side effects hub
- the most reported medicines and reactions